Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21,119	11,703	10,129	8,835	10,576	10,702
Market Cap Growth	118.15%	15.54%	14.65%	-16.46%	-1.18%	-36.29%
Enterprise Value	37,987	30,334	30,275	31,945	35,841	38,076
Last Close Price	18.64	10.44	9.12	8.01	9.65	9.80
PE Ratio	-	-20.88	-4.14	21.17	-2.65	-10.70
PS Ratio	1.29	0.74	0.68	0.56	0.63	0.63
PB Ratio	3.32	1.44	1.18	0.79	0.96	0.71
P/FCF Ratio	31.10	13.90	9.72	37.44	16.58	47.99
P/OCF Ratio	18.08	8.55	6.37	11.07	8.70	14.31
EV/Sales Ratio	2.33	1.91	2.03	2.01	2.15	2.25
EV/EBITDA Ratio	8.32	7.00	7.63	7.25	7.77	8.58
EV/EBIT Ratio	10.90	9.54	11.37	10.38	11.73	14.02
EV/FCF Ratio	55.95	36.03	29.05	135.36	56.18	170.75
Debt / Equity Ratio	2.88	2.49	2.52	2.10	2.40	1.82
Debt / EBITDA Ratio	4.03	4.53	5.26	5.19	5.57	5.95
Debt / FCF Ratio	27.87	24.08	20.80	99.97	41.59	123.14
Asset Turnover	0.39	0.36	0.33	0.32	0.31	0.29
Inventory Turnover	2.05	2.09	2.08	2.02	2.02	2.04
Quick Ratio	0.46	0.54	0.57	0.61	0.51	0.56
Current Ratio	0.89	1.02	1.05	1.14	0.99	0.98
Return on Equity (ROE)	-10.51%	-7.35%	-25.19%	4.09%	-31.38%	-6.49%
Return on Assets (ROA)	5.16%	4.54%	3.63%	3.91%	3.53%	2.87%
Return on Capital (ROIC)	8.04%	6.77%	5.11%	5.31%	4.77%	3.89%
Earnings Yield	-2.14%	-4.78%	-24.15%	4.72%	-37.73%	-9.33%
FCF Yield	3.22%	7.19%	10.29%	2.67%	6.03%	2.08%
Buyback Yield / Dilution	-0.85%	-0.81%	-0.27%	-1.10%	-0.37%	-6.86%
Total Shareholder Return	-0.85%	-0.81%	-0.27%	-1.10%	-0.37%	-6.86%

Source: S&P Capital IQ. Standard template. Financial Sources.